Hepcludex® (Bulevirtide) Demonstrates Sustained Efficacy and Safety Profile in People With Chronic Hepatitis Delta Virus at 96 Weeks streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Continued Treatment with Bulevirtide Shows Clinical Benefit and Sustained Viral Decline with Prolonged Treatment in Patients Originally Considered Partial- or Non-Responders Gilead Sciences, Inc. (NASDAQ:GILD)
Didier Raoult A leading microbiology society has issued expressions of concern for four six papers from a group in France led by the controversial scientist Didier Raoult, whose lab is under investigation by the University of Aix Marseille for “serious malfunctions.” The move follows the release last month of a 157-page report by investigators related…
Worldwide Tissue Engineered Skin Substitutes Markets to 2025 with Profiles of Major Players Smith & Nephew, Molnlycke Health Care, and Integra LifeSciences Among Others
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Tissue Engineered Skin Substitutes Market is estimated to be USD 695 million in 2020 and is expected to reach USD 845.6 million by 2025, growing at a CAGR of 4%.
Market Dynamics
Key factors, such as increasing prevalence of acute and chronic wounds, growing burn & trauma cases, rising demand for skin grafts, and rising focus on technological advancements have led to a rise in tissue engineered skin substitutes market.